Brian Holmes is the first man in the UK and the fifth in the world to receive the treatment.
The milestone procedure went well, with patient Paul Buxton saying he felt "fantastic".
A slow NHS rollout has so far limited wide-ranging eligibility, meaning many patients have turned to private healthcare.
ELV001 aiming to disrupt the treatment paradigm for patients with incomplete response to standard of care (methotrexate + TNF inhibitors)Phase 2b trial enrolling approximately 180 patients across nine ...
MANCHESTER — Two ongoing cardiology trials in the UK are facing substantial recruitment challenges, researchers reported at the British Cardiovascular Society (BCS) Annual Conference 2025. The BRITISH ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results